Traumatic Optic Neuropathy Treatment Trial (TONTT)

NCT01783847 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

117

Enrollment

OTHER

Sponsor class

Conditions

Traumatic Optic Neuropathy

Interventions

DRUG: Recombinant human erythropoietin (EPO)
OTHER: Observation
DRUG: Methyl prednisolone

Sponsor

Tehran University of Medical Sciences

Collaborators

[object Object]
[object Object]
[object Object]